Litcius/Paper detail

Characterization of the Immune Landscape of EGFR-Mutant NSCLC Identifies CD73/Adenosine Pathway as a Potential Therapeutic Target

Xiuning Le, Marcelo V. Negrão, Alexandre Reuben, Lorenzo Federico, Lixia Diao, Daniel J. McGrail, Monique B. Nilsson, Jacqulyne Robichaux, Irene Guijarro Munoz, Sonia Patel, Yasir Y. Elamin, You-Hong Fan, Won-Chul Lee, Edwin R. Parra, Luisa M. Solis Soto, Runzhe Chen, Jun Li, Tatiana V. Karpinets, Roohussaba Khairullah, Humam Kadara, Carmen Behrens, Boris Sepesi, Ruiping Wang, Mingrui Zhu, Linghua Wang, Ara A. Vaporciyan, Jack A. Roth, Stephen G. Swisher, Cara Haymaker, Jianhua Zhang, Jing Wang, Kwok‐Kin Wong, Lauren A. Byers, Chantale Bernatchez, Jianjun Zhang, Ignacio I. Wistuba, Don L. Gibbons, Esra A. Akbay, John V. Heymach

2020Journal of Thoracic Oncology124 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAdenosineBlockadeMutantImmune systemImmune checkpointCancer researchImmunotherapyWild typeTargeted therapyImmunologyCancerInternal medicineReceptorBiologyGeneticsGeneAdenosine and Purinergic SignalingCancer Immunotherapy and BiomarkersCancer Research and Treatments